Treatment Selection of JAK Inhibitors for the Management of

Expert dermatologists speak on shared-decision making between the patient and the provider when it comes to selecting the right therapy for AD.

Related Keywords

Christopher Bunick , Lisa Swanson , Alexandra Golant , , Peter Lio , Jak Inhibitors , Experience , Dosing , Switching , Inadequate , Response , Systemic , Topical , Suppressed Disease , Standard Of Care ,